Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease, and Parkinson’s disease, Huntington’s disease and Amyotrophic Lateral Sclerosis -An updated review
Taha Alqahtani, S. L. Deore, Anjali A. Kide, et al.
Mitochondrion (2023) Vol. 71, pp. 83-92
Closed Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Therapeutic potential of Coumarin-polyphenolic acid hybrids in PD: Inhibition of α-Syn aggregation and disaggregation of preformed fibrils, leading to reduced neuronal inclusion formation
Zhenping Wang, Wei Zhang, Li-Zi Xing, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 99, pp. 129618-129618
Closed Access | Times Cited: 2
Transgenerational hormesis in healthy aging and antiaging medicine from bench to clinics: Role of food components
Vittorio Calabrese, Naomi Osakabe, Rosalba Siracusa, et al.
Mechanisms of Ageing and Development (2024) Vol. 220, pp. 111960-111960
Closed Access | Times Cited: 2
Postbiotics as Molecules Targeting Cellular Events of Aging Brain—The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases
Pola Głowacka, Katarzyna Oszajca, Agnieszka Pudlarz, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2244-2244
Open Access | Times Cited: 2
Nrf2 pathways in neuroprotection: Alleviating mitochondrial dysfunction and cognitive impairment in aging
Asif Ahmad Bhat, Ehssan Moglad, Ahsas Goyal, et al.
Life Sciences (2024) Vol. 357, pp. 123056-123056
Closed Access | Times Cited: 2
Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
A. Tolédano, Arantxa Rodrı́guez-Casado, María‐Isabel Álvarez, et al.
Brain Sciences (2024) Vol. 14, Iss. 11, pp. 1101-1101
Open Access | Times Cited: 2
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer’s Disease: A Critical Review of New and Old Little Regarded Findings
Anna Atlante, Daniela Valenti
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15951-15951
Open Access | Times Cited: 7
Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease
Betina Awuson-David, Adrian Williams, Benjamin Wright, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 6
Temperature- and chemical-induced neurotoxicity in zebrafish
Mattia Toni, Chiara Arena, Carla Cioni, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 6
Non-coding RNA and Atherosclerosis
Aram Adyan, Evgeny E. Bezsonov, Eugene S. Grebenshchikov, et al.
Gene Expression (2024) Vol. 23, Iss. 1, pp. 57-68
Open Access | Times Cited: 1
Synergistic Approaches in Neurodegenerative Therapeutics: Multi-Target Drug Innovative Interventions for Alzheimer’s Disease
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
(2024)
Open Access | Times Cited: 1
Role of Exosomes in Parkinson’s and Alzheimer’s Diseases
Himanshu Sharma, Siddhant Jai Tyagi, Phool Chandra, et al.
(2024), pp. 147-182
Closed Access | Times Cited: 1
ZLN005 alleviates PBDE-47 induced impairment of mitochondrial translation and neurotoxicity through PGC-1α/ERRα axis
Zhiyuan Tian, Jing Li, Huayang Tang, et al.
Journal of Hazardous Materials (2024) Vol. 471, pp. 134331-134331
Closed Access | Times Cited: 1
Psammaplin A and Its Analogs Attenuate Oxidative Stress in Neuronal Cells through Peroxisome Proliferator-Activated Receptor γ Activation
Rebeca Alvariño, Amparo Alfonso, Jioji Tabudravu, et al.
Journal of Natural Products (2024) Vol. 87, Iss. 4, pp. 1187-1196
Open Access | Times Cited: 1
Functional implications of NHR-210 enrichment in C. elegans cephalic sheath glia: insights into metabolic and mitochondrial disruptions in Parkinson's disease models
Rohil Hameed, Anam Naseer, Ankit Saxena, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Embracing complexity of (brain) aging
Maria Cristina Polidori
FEBS Letters (2024)
Open Access | Times Cited: 1
TRABD modulates mitochondrial homeostasis and tissue integrity
Caixia Zhou, Zhirong Li, Yawen Li, et al.
Cell Reports (2024) Vol. 43, Iss. 6, pp. 114304-114304
Open Access | Times Cited: 1
Harnessing the Therapeutic Potential of Peptides for Synergistic Treatment of Alzheimer’s Disease by Targeting Aβ Aggregation, Metal-Mediated Aβ Aggregation, Cholinesterase, Tau Degradation, and Oxidative Stress
Kamaljot Singh, Anupamjeet Kaur, Bhupesh Goyal, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 14, pp. 2545-2564
Closed Access | Times Cited: 1
Pathological Defects in a Drosophila Model of Alzheimer’s Disease and Beneficial Effects of the Natural Product Lisosan G
Silvia Bongiorni, Elisabetta Catalani, Ivan Arisi, et al.
Biomolecules (2024) Vol. 14, Iss. 7, pp. 855-855
Open Access | Times Cited: 1
Application of Casein Micelles for Targeting Huntington’s Disease in Experimental Zebrafish Model
Deepak Nagdiya, Sanchit Arora, Vishal Kumar, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 1
Preclinical alternative drug discovery programs for monogenic rare diseases. The case of hereditary spastic paraplegias
Matteo Rossi Sebastiano, Shinji Hadano, Fabrizia Cesca, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 10, pp. 104138-104138
Open Access | Times Cited: 1
Oxidative Stress and Mitochondrial Dysfunction in Alzheimer's Disease: Insights into Pathophysiology and Treatment
Amer E. Alkhalifa, Oula Alkhalifa, Iva Durdanovic, et al.
(2024)
Open Access | Times Cited: 1
Microglia in Neurodegenerative Diseases
Ifeoluwa O. Awogbindin, Michael Wanklin, Alexei Verkhratsky, et al.
Advances in neurobiology (2024), pp. 497-512
Closed Access | Times Cited: 1
The Imidazoline Receptors as a new therapeutic target in Huntington’s disease: A Preclinical Overview
Sakshi Jari, Nandini Ratne, Manasi Tadas, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102482-102482
Closed Access | Times Cited: 1
Neurotoxic mechanisms of dexamethasone in SH-SY5Y neuroblastoma cells: Insights into bioenergetics, oxidative stress, and apoptosis
Ekramy Elmorsy, Ayat B. Al‐Ghafari, Huda A. Al Doghaither, et al.
Steroids (2024), pp. 109514-109514
Closed Access | Times Cited: 1
Dual Color Carbon Dots for Simultaneous Dynamic Fluorescence Tracking of Mitochondria and Lysosomes
Xinlu Li, Tongtong Zhu, Xiangli Quan, et al.
Sensors and Actuators B Chemical (2024), pp. 136678-136678
Closed Access | Times Cited: 1

Scroll to top